Cargando…
Heparan sulfate mediates trastuzumab effect in breast cancer cells
BACKGROUND: Trastuzumab is an antibody widely used in the treatment of breast cancer cases that test positive for the human epidermal growth factor receptor 2 (HER2). Many patients, however, become resistant to this antibody, whose resistance has become a major focus in breast cancer research. But d...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850728/ https://www.ncbi.nlm.nih.gov/pubmed/24083474 http://dx.doi.org/10.1186/1471-2407-13-444 |